Bio-Techne (TECH) Misses Q4 EPS by 3c

Bio-Techne (NASDAQ: TECH) reported Q4 EPS of $2.05, $0.03 worse than the analyst estimate of $2.08. Revenue for the quarter came in at $288.2 million versus the consensus estimate of $287.12 million.

For earnings history and earnings-related data on Bio-Techne (TECH) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Reading (RDI) Tops Q2 EPS by 4c
• Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c